Nymox Pharmaceutical Corp. sell StockNews.com
Start price
17.06.23
/
50%
€0.35
Target price
17.06.24
-
Performance (%)
-33.91%
Price
06.07.23
€0.23
Summary
This prediction is currently active. Massive losses of -33.91% have been the result for the SELL prediction by StockNews_com. This prediction currently runs until 17.06.24. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Nymox Pharmaceutical Corp. | - | - |
iShares Core DAX® | 2.594% | -1.158% |
iShares Nasdaq 100 | 3.553% | -1.727% |
iShares Nikkei 225® | 0.687% | -8.354% |
iShares S&P 500 | 2.209% | -0.942% |
Comments by StockNews_com for this prediction
In the thread Nymox Pharmaceutical Corp. diskutieren
Nymox Pharmaceutical Co. (NASDAQ: NYMX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for NYMX provided by MarketBeat
Stopped prediction by StockNews_com for Nymox Pharmaceutical Corp.
Nymox Pharmaceutical Corp.
Start price
Target price
Perf. (%)
€0.29
25.06.23
25.06.23
-
25.06.24
25.06.24
-21.77%
06.07.23
06.07.23
Nymox Pharmaceutical Corp.
Start price
Target price
Perf. (%)
€0.43
30.04.23
30.04.23
-
30.04.24
30.04.24
-47.00%
06.07.23
06.07.23
Nymox Pharmaceutical Corp.
Start price
Target price
Perf. (%)
€0.41
22.04.23
22.04.23
-
22.04.24
22.04.24
-43.90%
23.04.24
23.04.24
Nymox Pharmaceutical Corp.
Start price
Target price
Perf. (%)
€0.36
05.03.23
05.03.23
-
05.03.24
05.03.24
-35.75%
06.03.24
06.03.24
Nymox Pharmaceutical Corp.
Start price
Target price
Perf. (%)
€0.36
26.02.23
26.02.23
-
26.02.24
26.02.24
-35.75%
27.02.24
27.02.24